| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
39,550,000 |
| Market
Cap: |
44.69(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.89 - $3.02 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 15 |
| Insider 6 Months : 15 |
| Insider 3/6 Months : 30.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TELA Bio is a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions. Co.'s main product, the OviTex Reinforced Tissue Matrix (OviTex), addresses needs in hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. Co. has designed an OviTex product for use in laparoscopic and robotic-assisted surgery called OviTex LPR. Co.'s other product, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses needs in plastic and reconstructive surgery. Co.'s OviTex PRS portfolio is supported by non-human primate data that demonstrated tissue integration and tissue remodeling.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
3,604,000 |
3,604,000 |
3,604,000 |
3,786,220 |
| Total Buy Value |
$4,000,440 |
$4,000,440 |
$4,000,440 |
$4,410,436 |
| Total People Bought |
1 |
1 |
1 |
5 |
| Total Buy Transactions |
1 |
1 |
1 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
428,300 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,022,000 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2025-09-21 |
2025-06-20 |
2024-12-20 |
2023-12-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ew Healthcare Partners Fund 2-Ugp, L.p. |
See Remarks |
• • • |
2025-11-17 |
4 |
B |
$1.11 |
$4,000,440 |
D/D |
3,604,000 |
7,714,709 |
0.01 |
- |
|
| Plovanic William J. |
|
– • – |
2025-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
11,925 |
11,925 |
|
- |
|
| Rocchio Betty Jo |
|
– • – |
2025-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,925 |
11,925 |
|
- |
|
| Firestone Gregory A. |
Chief Commercial Officer |
• – – |
2025-08-03 |
4 |
D |
$1.86 |
$2,033 |
D/D |
(1,093) |
106,790 |
|
- |
|
| Blizard Jeffrey |
President |
• – – |
2025-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
104,800 |
119,125 |
|
- |
|
| Blizard Jeffrey |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
14,325 |
|
- |
|
| Burgess Vincent J |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
23,330 |
|
- |
|
| Azarbarzin Kurt |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
18,470 |
|
- |
|
| Obrien Federica F. |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
18,470 |
|
- |
|
| Colleran Lisa N |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
18,470 |
|
- |
|
| Evans Douglas G |
Director |
– • – |
2025-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
18,470 |
|
- |
|
| Talmo Paul |
Chief Technology Officer |
• – – |
2025-03-31 |
4 |
D |
$1.22 |
$232 |
D/D |
(190) |
123,882 |
|
- |
|
| Smeykal Megan |
Chief Accounting OfficerContro |
• – – |
2025-03-31 |
4 |
D |
$1.22 |
$117 |
D/D |
(96) |
36,831 |
|
- |
|
| Firestone Gregory A. |
Chief Commercial Officer |
• – – |
2025-03-31 |
4 |
D |
$1.22 |
$145 |
D/D |
(119) |
106,804 |
|
- |
|
| Koblish Antony |
Chief Executive Officer |
• • – |
2025-03-31 |
4 |
D |
$1.22 |
$468 |
D/D |
(384) |
590,110 |
|
- |
|
| Smeykal Megan |
Chief Accounting OfficerContro |
• – – |
2025-02-24 |
4 |
D |
$2.65 |
$1,428 |
D/D |
(539) |
36,927 |
|
- |
|
| Talmo Paul |
Chief Technology Officer |
• – – |
2025-02-24 |
4 |
D |
$2.65 |
$2,780 |
D/D |
(1,049) |
124,072 |
|
- |
|
| Koblish Antony |
Chief Executive Officer |
• • – |
2025-02-24 |
4 |
D |
$2.65 |
$15,296 |
D/D |
(5,772) |
590,494 |
|
- |
|
| Firestone Gregory A. |
Chief Commercial Officer |
• – – |
2025-02-24 |
4 |
D |
$2.65 |
$636 |
D/D |
(240) |
106,923 |
|
- |
|
| Smeykal Megan |
Chief Accounting OfficerContro |
• – – |
2025-02-23 |
4 |
D |
$2.72 |
$1,151 |
D/D |
(423) |
37,466 |
|
- |
|
| Talmo Paul |
Chief Technology Officer |
• – – |
2025-02-23 |
4 |
D |
$2.72 |
$11,046 |
D/D |
(4,061) |
125,121 |
|
- |
|
| Koblish Antony |
Chief Executive Officer |
• • – |
2025-02-23 |
4 |
D |
$2.72 |
$31,636 |
D/D |
(11,631) |
596,266 |
|
- |
|
| Firestone Gregory A. |
Chief Commercial Officer |
• – – |
2025-02-23 |
4 |
D |
$2.72 |
$3,677 |
D/D |
(1,352) |
107,163 |
|
- |
|
| Cuca Roberto |
COO and CFO |
• – – |
2025-02-23 |
4 |
D |
$2.72 |
$14,236 |
D/D |
(5,234) |
208,233 |
|
- |
|
| Smeykal Megan |
Chief Accounting OfficerContro |
• – – |
2025-02-21 |
4 |
D |
$2.72 |
$4,325 |
D/D |
(1,590) |
37,889 |
|
- |
|
358 Records found
|
|
Page 1 of 15 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (0.88%) 
